NEW DELHI, Feb 07 (IPS) – The year 2021 began with several new vaccines showing efficacy in randomized trials, but despite 26 authorised Covid-19 vaccines globally, and at least another 200 in development (The Lancet, 2021), the first few weeks of year 2022 brought a sense of uncertainty.
Read the full story, “An Unending & Uncertain Battle Against the Covid”, on globalissues.org →